5:49 PM
 | 
Dec 26, 2012
 |  BC Extra  |  Company News

Takeda, Amylin terminate obesity deal

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said it and Amylin Pharmaceuticals Inc. mutually terminated a 2009 deal to co-develop and...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >